# A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller

> **NCT04092582** · PHASE2 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 135 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MTPS9579A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04092582
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-31
- **Primary completion:** 2022-05-19
- **Final completion:** 2022-05-19
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04092582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04092582, "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT04092582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*